Skip to main content

Delhi High Court vacates ex parte injunction granted against defendant finding permeation of its trans-border reputation and plaintiff’s mis-statement of facts in pleadings in case involving rival claims to the PARAMOUNT mark.

The defendant, a Japanese company, adopted the PARAMOUNT mark in 1987 for its business in hospital beds and holds registrations of the mark in other countries albeit not in India.

The plaintiff on the basis of its registration of the same mark in India, and averring that the defendant’s adoption of the PARAMOUNT mark was dishonest and that it had learnt of this adoption only in 2017, obtained an ex parte interim injunction from the Single Judge of the Delhi High Court.

The Judge later set aside the injunction order after a hearing spanning several dates during which she observed that the plaintiff did not approach the court with clean hands. Among other mis-statements and questionable conduct, the plaintiff had made patently incorrect statements regarding its knowledge of the defendant’s prior use of mark. Specifically, the plaintiff had opposed the defendant’s trademark application in 2009 and the two parties had exchanged settlement related correspondence in 2012.

The court accepted that the defendant has a large business presence and tremendous reputation and goodwill vested in the PARAMOUNT mark in India. Its trans-border reputation had also permeated into India.
The court held that the plaintiff had failed to establish a prima facie case in its favour and found the balance of convenience was in favour of the defendant.

Paramount Surgimed Limited v Paramount Bed India Private Limited; before the Delhi High Court; judgment dated 25.05.2017

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions
Thought Leadership
•
Oct 15, 2026

First published on Enterprise IT World. Authored by Subroto Kumar Panda Imagine you gave a supersmart robot a credit card and told it to “buy the best

Taming the AI Beast: How Big Companies Build Safe AI Agents